BeStock  
Stocks › Biotechnology › BBIO

BridgeBio Pharma BBIO

US equityMarket cap rank #1114Biotechnology
$76.03 −$2.15 (-2.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $76.03 0.00%
Open$77.85
Prev close$78.18
Day range$75.46 – $78.24
Volume1.48M
Market cap$14.81B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-25.1x
CheapRich

Near the bottom of its 5-year range · 1st percentile, 5-year average -9.9x

Price / book-5.7x
CheapRich

Below its usual level · 22nd percentile, 5-year average -4.1x

Price / sales15.7x
CheapRich

Near the bottom of its 5-year range · 6th percentile, 5-year average 126.3x

#4696 of 5161 stocks by PS (1 = cheapest)

P/E over five years

-28x-18x-9x0xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$85.00
Price vs. fair value-10.6%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -5.69 – -4.10 22% (cheaper than usual) –
PE -25.09 -38.67 -9.90 1% (cheaper than usual) –
PS 15.66 10.08 126.34 6% (cheaper than usual) #4696 of 5161 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on BBIO.

Sign in to join the discussion.

Scroll to Top